atherosclerosis l-carnitine Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC l carnitine and atrial fibrillation Proposed mechanisms for the interaction between the gut microbiome Carnitine metabolism in hypertensive heart Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota ScienceDirect Metabolite acetyl L carnitine participates in Bifidobacterium animalis F1 7 to ameliorate atherosclerotic inflammation by downregulating theTLR4 NF B pathway ScienceDirect
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



